SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000278
Filing Date
2024-05-31
Accepted
2024-05-31 16:38:32
Documents
2
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3850
2 POWER OF ATTORNEY poa.htm EX-24.1 7446
  Complete submission text file 0001610717-24-000278.txt   12842
Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451
Business Address
Kelley Susan L. (Reporting) CIK: 0001519612 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38915 | Film No.: 241010348

Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Issuer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)